<DOC>
	<DOCNO>NCT02423174</DOCNO>
	<brief_summary>The objective clinical trial determine suitability FMwand Ferromagnetic Surgical System Total Mesorectal Excision Surgery .</brief_summary>
	<brief_title>Eval . Safety Effectiveness FMwand Ferromagnetic Surgical System During Total Mesorectal Excision Surgery</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>Confirmed rectal cancer lower twothirds rectum ( high T2 N0 N+ ) Amenable standard surgery procedure use electrocautery , argon beam , laser conventional tissue removal modality ECOG status ≤ 2 Life expectancy &gt; 3 month Age ≥ 18 year old Age ≤ 80 year old Ability provide write informed consent HIPAA form prior admission study Willingness meet expect requirement clinical protocol Patient metastasis History radiotherapy chemotherapy treatment rectal cancer Uremia BUN &gt; 40 Hemodialysis Existing urinary fecal incontinence Pregnant lactate Previously diagnose coagulopathy bleed diathesis Currently , within previous 10 day prior surgery , take medication would produce bleed diathesis include limited , Plavix , warfarin , NSAIDs , clopidogrel , ticlopidine valproic acid History significant cardiac disorder would necessitate special fluid management protocol History acute myocardial infarction and/or acute angina INR &gt; 1.4 24 hour prior surgery PTT &gt; 40 24 hour prior surgery Platelet count &lt; 100K 24 hour prior surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>